Location: DIBIT1 A3, Floor 2, Room 51
Group leader, Liver gene therapy Unit
Alessio Cantore has received a Ph.D. in cellular and molecular biology in 2013 by the Open University, London, and “Vita-Salute San Raffaele” University under the supervision of Prof. Luigi Naldini, Prof. Thierry VandenDriessche (Free University of Brussels) and Prof. Maria Grazia Roncarolo. He has made important contributions to the field of liver-directed gene therapy by evaluating the efficacy and safety of systemic lentiviral vector administration in different experimental models and engineering vectors with enhanced biological properties, reduced immunogenicity and high potency.
He has published 12 original research articles and 3 review articles on peer-reviewed international scientific journals (h-index: 13) and is inventor of 6 patents. He has been invited to speak at several international conferences and is recipient of various awards, including the 2018 Young Investigator Award, from the European Society of Gene and Cell Therapy, a 2019 Excellence in Research Award from the American Society of Gene and Cell Therapy. Since 2017 he serves as Assistant Professor of Histology at “Vita-Salute San Raffaele” University and since 2020 is Group Leader at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget). He is also scientific co-founder of GeneSpire, an innovative Start-up company aimed to develop liver-directed gene therapy for inherited metabolic diseases.